drugset / Trial / NCT06632600
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to investigate the ability of LXE408 to clear or reduce the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without severe organ dysfunction.
Timeline
- Start
- 2025-04-28
- Primary completion
- 2027-03-22
- Completion
- 2030-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Benznidazole | Small molecule | — | Oral |
| Subject | LXE408 | Small molecule | — | Oral |